期刊文献+

前列腺特异膜抗原剪接变异体的基因结构和多态性分析 被引量:2

Analysis of gene structure and diversity of new alternative spliced variants of prostate specific membrane antigen
下载PDF
导出
摘要 目的:了解PSMA剪接变异体的结构及其多样性,探讨前列腺癌的发生机制。方法:应用cDNA末端快速扩增(RACE)的方法扩增剪接变异体5和3末端,并进行序列测定,分析前列腺癌组织PSMA剪接变异体的结构及其多样性。结果:从前列腺癌组织中发现4种新的PSMA剪接变异体,与已往报道的PSMA剪接变异体相比,新发现的变异体在不同位点存在不同程度的插入及缺失。结论:本研究所发现的新PSMA剪接变异体证实和丰富了PSMA剪接变异体的多样性,为寻求前列腺癌特异性的诊断标志物和治疗靶点提供了新的线索和思路。 AIM: To find out the gene structure and diversity of protate specific membrane antigen (PSMA) alternative spliced variants, and probe into the pathogenesis of prostate cancer. METHODS : 5' - RACE and 3' - RACE methods were used to amplify the 5' and 3'end of alternative spliced variant and then those viariants were sequenced for analyzing the gene stucture and diversity of PSMA alternative spliced variants of prostate cancer tissues. RESULTS : Four new alternative spliced variants of PSMA were discovered from prostate cancer tissues. Compared with reported PSMA alternative spliced variants, different insertions and deletions existed in different sites of those new variants. CONCLUSION: The discovery of the new variants confirms the diversity of PSMA spliced variants and provides the clues for seeking the target of diagnosis and therapy of prostate cancer.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2006年第12期2377-2379,共3页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30371426) 广东省自然科学基金重点资助项目(No.021907)
关键词 前列腺特异抗原 剪接 前列腺肿瘤 Prostate -specific antigen Splice variant Prostatic neoplasms
  • 相关文献

参考文献9

  • 1Modrek B, Resch A, Grasso C, et al. Genome -wide detection of alternative splicing in expressed sequences of human genes[J]. Nucleic Acid Res, 2001, 29(13) : 2850- 2859.
  • 2Wang Z, Lo HS, Yang H, et al. Computational analysis and experimental validation of tumor associated alternative RNA splicing in human cancer [ J ]. Cancer Res, 2003,63 ( 3 ) : 655 - 665.
  • 3Israeli RS, Powell CF, Fair WR, et al. Molecular cloning of a complementary DNA encoding a prostate - specific membrane antigen[J]. Cancer Res, 1993, 53(2) : 227 -230.
  • 4曹开源,戴淑琴,徐霖中,袁广卿,黄小荣,丘少鹏,郭琳洁.中国人前列腺特异膜抗原基因真核表达载体的构建和序列测定[J].中国病理生理杂志,2004,20(6):1009-1012. 被引量:1
  • 5曹开源,戴淑琴,肖娜,徐霖,袁广卿,丘少鹏,黄小荣.新型前列腺特异膜抗原剪接变异体的发现及临床意义初步探讨[J].中国病理生理杂志,2006,22(11):2185-2188. 被引量:7
  • 6Schmittgen TD, Teske S, Vessella RL, et al. Expression of prostate specific membrane antigen and three ahernative spliced variants of PSMA in prostate cancer patients [ J ].Int J Cancer, 2003,107(2) : 323 -329.
  • 7Tarn W, Steitz J. Pre - mRNA splicing: the discovery of a new spliceosome doubles the challenge[ J]. TIBS, 1997,22(4) : 132 - 137.
  • 8Yang DC, Jiang XP, Elliott RL, et al. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene[ J ].Anticancer Res, 2001, 21(3B) : 1777- 1787.
  • 9刘玉峰.肿瘤细胞的铁代谢及其调节[J].中国小儿血液,2005,10(1):40-42. 被引量:2

二级参考文献40

  • 1Damell G, Richardson DR. The potential of analogues of the pyridoxal isonicotinoyl hydrazone class as effective anti - proliferative agen ts Ⅲ:the effect of the ligands on molecular targets involved in proliferation.Blood, 1999;94:781.
  • 2Richardson DR, Ponka R The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta, 1997;1331:1.
  • 3Lesnikov V, Lesnikova M, Deeg HJ. Pro- apoptotic and anti - apoptotic effects of transferrin and transferrin - derived glycans on hematopoietic cells and lymphocytes. Exp Hematol, 2001 ;29(4) :477.
  • 4Yang DC, Jiang XP, Elliott RL, et al. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene. Anticancer Res, 2001; 21 ( 3B ): 1777.
  • 5Xu L, Tang WH, Huang CC, et al. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti - transferrin receptor scFv. Mol Med, 2001;7(10):723.
  • 6Yang DC, Wang F, Elliott RL, et al. Expression of transferrin receptor and ferritin H - chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Anticancer Res, 2001;21(1B):541.
  • 7Fleming RS, Migas MC, Holden CC, et al. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci USA, 2000;97:2214.
  • 8Kawabata H, Gennain RS, Ikezoe T, et al. Regulation of expression of murine transfemn receptor 2. Blood, 2001 ;98(6): 1949.
  • 9Picard V, Epsztejn S, Santambrogio P, et al. Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells. J Biol Chem,1998;273(25): 15382.
  • 10Wang J, Pantopoulos K. Conditional derepression of ferritin synthesis in cells expressing a constitutive IRP1 mutant. Mol Cell Biol, 2002; 22(13) :4638.

共引文献7

同被引文献18

  • 1曹开源,戴淑琴,肖娜,徐霖,袁广卿,丘少鹏,黄小荣.新型前列腺特异膜抗原剪接变异体的发现及临床意义初步探讨[J].中国病理生理杂志,2006,22(11):2185-2188. 被引量:7
  • 2Zhang J, Hsu B A JC, Kinseth B A MA, et al. Indole - 3 - carbinol induces a G1 cell cycle arrest and inhibits prostate - specific antigen production in human LNCaP prostate carcinoma cells [J]. Cancer, 2003, 98 ( 11 ) : 2511 - 2520.
  • 3Haag P, Bektic J, Bartsch G, et al. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells [ J ]. J Steriod Biochem Mol Biol, 2005, 96(3 -4) : 251 -258.
  • 4Park HY, Kim MK, Moon SI, et al. Cell cycle arrest and apoptotic induction in LNCaP cells by MCS - C2, novel cyclin- dependent kinase inhibitor, through p53/ p21^WAF1/CIP1 pathway[J]. Cancer Sci, 2006, 97(5): 430 - 436.
  • 5Lu S, Ren C, Liu Y, et al. PI3K - Akt signaling is involved in the regulation of p21 (WAF/CIP) expression and androgen- independent growth in prostate cancer cells [J] . Int J Oncol, 2006, 28 ( 1 ) : 245 - 251.
  • 6Agus DB, Cordon - Cardo C, Fox W, et al. p21^WAF1/GIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation [ J ]. Prostate Cancer Prostatic Dis, 2005, 8(4) : 321 -326.
  • 7Bataller M, Portugal J. Apoptosis and cell recovery in response to oxidative stress in p53 - deficient prostate carcinoma cells [ J ]. Arch Biochem Biophys, 2005, 437 (2) : 151 - 158.
  • 8Zhang S, Murtha PE, Young CY. Defining a functional androgen responsive element in the 5'far upstream flanking region of the prostate- specific antigen gene[J]. Biochem Biophys Res Commun, 1997, 231(3) : 784 - 788.
  • 9Brawer MK. Assays for complexed prostate - specific antigen and other advances in the diagnosis of prostate cancer [J]. Rev Urol, 2003, 5(Suppl 6) : S10 -S16.
  • 10Gould DC, Feneley MR, Kirby RS. Prostate- specific antigen testing in hypogonadism: implications for the safety of testosterone - replacement therapy [ J ]. Urologe A, 2006, 45(8) : 1002 - 1005.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部